On Nov 04, Nanavaty Maulik, SVP & Pres, Neuromodulation exercised an option 9,623 shares of Boston Scientific Corporation (NYSE: BSX), with the average selling price of the stock being $13.08 per share. The total amount realized from this exercised an option $125,869. A document was filed with the Securities and Exchange Commission to notify the public about the exercised an option of the shares.
In addition to that, SVP & Pres, Neuromodulation – Nanavaty Maulik sold an extra 9,623 shares of this stock in a transaction that took place a day before, on Nov 04, with a share sold at an average of $41.66 and a total of $400,894 was realized from this transaction. After the transaction, the SVP & Pres, Neuromodulation – Nanavaty Maulik was left with 255,194 shares of the company’s stock, which is currently worth around $10631382.04.
The recent price movement of BSX means that it is now down by -7.12% from its 52-week high and 29.02% up against its 52-week low prices. Over the past one week, the price volatility of BSX stands at 2.06% while the volatility over the past one month is 1.98%. The beta score for this stock is 0.77. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company on 10/23/2019 published its latest quarterly earnings, with the report showing that the company recorded 0.39 earnings per share (EPS) during that period. This report was above the expectations of analysts of 0.37 by 0.02. The revenue by the firm was 2.93B for the quarter.
The shares of Boston Scientific Corporation (BSX) dropped by 0.00%, leading to a loss of $0.0 per share, and saw BSX end the trading session at $40.72 on Thursday 11/07/19. BSX started the trading session at $40.76, before reaching a daily high of $41.03. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $40.3331.
The trading volume on Thursday stood at 4418570, which was below the stock’s 3-month average volume of 6.73 million shares, out of a total 1.39B shares. As the price of the stock dipped, the market valuation of the company dropped to 56.98 billion.
The shares of Ameriprise Financial Inc. (NYSE: AMP) went down by -0.08% by the end of the recent trading session. This movement saw its price plunge to close at $157.74, which was lower than the previous closing price of $157.87. Over the past one week, the price of AMP has jumped by 4.54%, while it has recorded a gain of 19.33% over the past one month. Its three-month performance saw AMP gain 19.66% while its six-month performance saw it surge by 9.12%. The situation is different though over the past one year, as the stock price went up by 23.67%, while its year-to-date (YTD) price performance jumped by 51.14%. The stock price has gone up by +29.75% compared to its 90-day low, while it is down -1.80% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Buy. In the short-term, the stock has a 20-day average volume of 806,190 shares, with the short-term indicators averagely rating the stock as a 100% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 978,160 shares and the indicators have an average rating of 100% Buy. The last indicators, the long-term see AMP stock with a 100-Day average volume of 997,833 shares, giving it an average rating of 100% Buy. A look at the general picture of all short, medium and long-term indicators leaves AMP with an average rating of 100% Buy.
Several brokerage firms sent out their reports AMP stock not long ago. In its report sent out on May 13, 2019, Credit Suisse lowered its ratings on AMP from a Neutral to a Outperform. In an earlier report on January 09, 2019, Barclays Upgrade the stock from a Equal Weight to a Overweight. Sandler O’Neill meanwhile in its report on January 02, 2019 Upgrade its rating of the stock from a “Buy” to “Buy”.
In related news to the company’s stock, around 90.20% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 861 institutions currently hold the AMP stock. In the last quarter, a 114,245,817 AMP shares were in the possession of institutions. On the other hand, the company recorded 98 new institutions who bought it their stock, while 61 institutions sold their entire AMP reserve. Of the current institutions investing in the stock, 360 increased their investment while 339 decreased their investment in the stock.